Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofimilast in Adults with COPD
NCT00219622Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of tofimilast in chronic obstructive pulmonary disease (COPD), sponsored by Pfizer. Started May 2004; status: completed.
02
Drugs
tofimilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00219622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219622.